Dr. Leszek Adam Balla

D.D.S. | Dentist



  
  1701 S 1st Ave, Suite 102, Maywood
  Illinois, 60153-2442

  708-450-5300    Maps & Directions
Dr. Leszek Adam Balla is a Maywood, Illinois based Dentist who is specialized in General Practice Dentistry. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 1701 S 1st Ave, Suite 102, Maywood. Patients can reach him at 708-450-5300.
Dr. Leszek Adam Balla is the primary dental care provider for patients of all ages. He is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Dr. Leszek Adam Balla speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Dr. Leszek Adam Balla
Specialization: Dentist
Gender:Male
Credentials: D.D.S.
Accepts Medicare Assignment:May Accept
Practice Address:1701 S 1st Ave, Suite 102, Maywood,
Illinois, 60153-2442
Phone:708-450-5300
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 0648582494
Enrollment ID: I20170626000528
NPI Number: 1346364411
NPI Enumeration Date: 16 Mar, 2007
NPI Last Update On: 21 Apr, 2021

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 3638 Crain St,
Skokie, Illinois
Zip: 60076-2352
Phone Number: 847-329-0972
Patients can reach Dr. Leszek Adam Balla at 1701 S 1st Ave, Suite 102, Maywood, Illinois or can call to book an appointment on 708-450-5300. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.

Comments/ Reviews: